1 / 39

CC Wong PYNEH

CC Wong PYNEH. Skin cancer. Non-melanoma Basal cell carcinoma Squamous cell carcinoma Dermatofibrosarcoma Merkel cell carcinoma Kaposi sarcoma Angiosarcoma Melanoma. Non-melanoma skin cancer. Non-melanoma skin cancer. Most common cancer in the USA

hagen
Télécharger la présentation

CC Wong PYNEH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CC Wong PYNEH

  2. Skin cancer • Non-melanoma • Basal cell carcinoma • Squamous cell carcinoma • Dermatofibrosarcoma • Merkel cell carcinoma • Kaposi sarcoma • Angiosarcoma • Melanoma

  3. Non-melanoma skin cancer

  4. Non-melanoma skin cancer • Most common cancer in the USA • Over 1,000,000 new cases in the USA per year • Fair skinned population

  5. Risk factors • Environmental factors • Sunlight exposure (Ultraviolet radiation) • Ionizing radiation • Chemical exposure eg. arsenic agent • Patient factors • Genetics disease • Precursor lesion • HIV and HPV infection

  6. UV radiation

  7. More carcinogenic 95%

  8. Basal cell carcinoma

  9. Basal cell carcinoma 75% of non-melanoma skin cancer Male : female = 3:2 Sunlight exposure Head & neck Slow growing Rarely metastasizes

  10. Basal cell carcinoma • Nodular • most common, pearly appearing papule • Pigmented • more frequent in darker-skinned population • Cystic • bluish or gray cystic nodule • Superficial • scaly patch-like lesion • pink to red to brown

  11. Basal cell carcinoma • Micronodular • aggressive variant • Morpheaform (infiltrating) • aggressive variant • scar-like appearance with ill-defined border

  12. Squamous cell carcinoma

  13. Squamous cell carcinoma Second most common skin cancer Male : female = 2-3:1 Sunlight exposure Old scar, chronic inflammation and ulcer Area of pre-exiting skin damage Faster growing

  14. Squamous cell carcinoma • Actinic keratosis: precursor • Bowen's disease: SCC in-situ • Unhealed ulcer with "heaped up" edge • Enlarging lesion irregular border • Cranial nerve dysfunction • perineural invasion

  15. Diagnosis Clinical diagnosis Incisional / excisional biopsy Imaging

  16. Treatment

  17. Surgical excision N.R. Telfer et al. British J of Dermatology. 2008 Murad Alam et al. N Engl J Med. 2001 • Major treatment method • High clearance rate • ~95% in both SCC and BCC • Low recurrence rate (in 5 year) • 5.8% in SCC, <2% in BCC

  18. How much margin should we take?

  19. BCC Lesion • Low risk • Trunk & extremities <2cm • Head &neck <1cm • Around eyes, ears, nose, mouth, hand and feet <6mm • High risk • Recurrent tumor • Immunocompromised • Previous radiation site • Perineural invasion • Micronodular, sclerosing, morpheaform Margin (mm) 4-5 10

  20. SCC Lesion • Low risk • Trunk & extremities <2cm • Head &neck <1cm • Around eyes, ears, nose, mouth, hand and feet <6mm • High risk • Recurrent tumor • Immunocompromised • Previous radiation site • Perineural invasion • Poorly differentiated • Adenoid, adenosquamous, desmoplastic Margin (mm) 4-5 10

  21. Facial H area

  22. Mohs' micrographic surgery Frederic E. Mohs in 1938 Complete circumferential peripheral and deep margin assessment Performed in stages / single day 5 year local control rate Murad Alam et al. N Engl J Med. 2001 Nicole W.J. et al. The Lancet 2004

  23. Mohs' micrographic surgery Preserve healthy skin tissue Time consuming High cost

  24. Mohs' micrographic surgery • Important site: • eyelids, ear, nose, lips, nasolabila fold, forehead, scalp or embryonic fusion plane • Recurrence • Size >2cm • Perineural involvement • Poorly defined margins in high-risk area Nicole W.J. et al. The Lancet 2004

  25. Radiation therapy • Primary vs adjuvant • 5-year local control rate ~90% • Multiple visits • No histological result • Side effect: dermatitis, telangiectasia • Contraindication: • Genetic condition eg. xeroderma pigmentosa • Connective tissue disease I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010

  26. Electrodesiccation and Curettage I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010 N.R. Telfer et al. British J of Dermatology. 2008 • Indication: • Small lesion <1cm • Superficial • Well-defined • 5-year local control rate: 95% in low risk BCC • Multiple attempts • No histopathology

  27. Cryotherapy I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010 N.R. Telfer et al. British J of Dermatology. 2008 Liquid nitrogen Frozen the skin -> tissue necrosis Multiple cycles 5-year recurrence rate: 8% in low risk BCC No histopathology Good cosmetic result

  28. Cryotherapy I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010 N.R. Telfer et al. British J of Dermatology. 2008 • Indication: Low risk BCC • Size <1cm • Superficial, nodular • Well-defined margin

  29. Topical immunotherapy • Imiquimod • Toll-like receptor 7 agonist • Modify the immune response -> antitumor activity -> tumor cell apoptosis • 5 application a week for 6 week • Indication: Small superficial BCC • Initial response rate 89.6% • Lack of long term data • Excellent cosmetic result I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010

  30. Photodynamic therapy Photosensitizing agent followed by illumination of visible light Produced activated oxygen molecule -> destroy target cell Usually 2 cycles 5-year recurrence rate: 14% Excellent cosmetic effect I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010

  31. Photodynamic therapy • Limited penetration • Indication: • Superficial lesion • Depth <2mm I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010

  32. 5-Fluorouracil • Topic chemotherapeutic agent • Blocking DNA synthesis • Apply twice a day for minimum 6 week • Cure rate: 93% • Indications: • Superficial BCC • Small ~1cm • Local inflammatory response I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010

  33. Interferon • Intralesional injection • Induce apoptosis • 3 injections per week for 3 week • Complete response rate: 50-80% • Indications: • Surgery could be disfiguring • Not a surgical candidate • Influenza-like symptom I.R. Aguayo-Leiva et al. Actas Dermosifiliogr. 2010

  34. Conclusion Non-melanoma skin cancer • Common • Rate of cure is high with proper treatment in local disease • Surgical excision is associated with lowest recurrence rate • Other non-surgical treatment • Early superficial disease • Non-surgical candidates

  35. Thank you

  36. SLN • No definite guideline • Lack of large scale study on non-melanoma skin cancer • Renzi et al.: 22 patients • Reschly et al.: 9 patients • Useful in high risk SCC

  37. Involved margin ~30-41% do not recur Re-excision of margin Mohs micrographic surgery Radiotherapy

More Related